Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SIGA TECHNOLOGIES INC Director's Dealing 2009

Aug 3, 2009

32600_dirs_2009-08-03_42c1dcaf-aac8-461c-8e90-7bfdcf6a9ecf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGA TECHNOLOGIES INC (SIGA)
CIK: 0001010086
Period of Report: 2009-07-30

Reporting Person: MJALLI ADNAN M M (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-07-30 Common Stock, par value $0.0001 per share ("Common Stock") S 1000000 $6.24 Disposed 2472222 Indirect

Footnotes

F1: On July 30, 2009, TransTech Pharma, Inc. sold 1,000,000 shares of Common Stock in a privately negotiated transaction to MacAndrews & Forbes LLC.

F2: The shares of Common Stock and the warrants are beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.